In a newborn with delayed umbilical‑cord separation and bleeding from the cord site, normal prothrombin time, activated partial thromboplastin time, platelet count and function, but prolonged clot formation time, which disorder is most likely?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Factor XIII Deficiency

The correct answer is C. Factor 13 deficiency. This newborn's presentation of delayed umbilical cord separation with bleeding and normal PT, PTT, platelet count, and platelet function—but prolonged clot formation time—is pathognomonic for Factor XIII deficiency 1.

Why Factor XIII Deficiency is the Answer

Factor XIII deficiency is the only coagulation disorder that presents with completely normal routine coagulation screening tests (PT, PTT, platelet count, and platelet function) because these tests only measure clot formation, not clot stability 1, 2. Factor XIII is responsible for cross-linking fibrin polymers to create mechanically stable clots 3. Without it, clots form normally but dissolve prematurely, leading to delayed bleeding 3.

Classic Clinical Presentation

  • Delayed umbilical cord separation (beyond 2-3 weeks) with bleeding from the umbilical stump is the hallmark neonatal presentation of Factor XIII deficiency 1, 4, 5
  • This occurs in approximately 80-90% of affected infants 5
  • The bleeding is characteristically delayed because the initial clot forms normally but then breaks down due to mechanical instability 1, 3

Laboratory Pattern

  • PT: Normal (extrinsic pathway intact) 1, 2
  • PTT: Normal (intrinsic pathway intact) 1, 2
  • Platelet count and function: Normal (primary hemostasis intact) 1, 2
  • Clot solubility test: Abnormal (clot dissolves in 5M urea or 1% monochloroacetic acid) 2, 5
  • Factor XIII activity assay: Low or absent (definitive diagnostic test) 1, 2

Why the Other Options Are Incorrect

A. Factor VIII Deficiency (Hemophilia A)

Factor VIII deficiency would prolong the PTT, not leave it normal 1, 6. Factor VIII is part of the intrinsic coagulation pathway, and its deficiency causes prolonged PTT with normal PT 6. The explicitly normal PTT in this case rules out Factor VIII deficiency 1.

B. Von Willebrand Disease

Von Willebrand disease would typically show abnormal platelet function testing and may prolong the PTT in severe cases 1, 6. The platelet function is explicitly normal in this case, excluding von Willebrand disease 1. Additionally, von Willebrand disease does not typically cause severe umbilical stump bleeding in newborns 6.

D. Thrombocytopenia

Thrombocytopenia is definitively ruled out by the normal platelet count 1, 6. By definition, thrombocytopenia requires a low platelet count, which is not present in this case 6.

Diagnostic Approach

Initial Screening

When routine coagulation tests (PT, PTT, platelet count) are normal but clinical bleeding occurs, Factor XIII deficiency must be specifically considered and tested for 1, 4:

  1. Order Factor XIII activity assay (not detected by routine panels) 1, 2
  2. Perform clot solubility test (5M urea test) as a rapid screening method 2, 5
  3. Consider Factor XIII antigen assay to distinguish type I (quantitative) from type II (qualitative) deficiency 2

Critical Pitfall

The most common diagnostic error is failing to consider Factor XIII deficiency because routine coagulation tests are normal 4, 2. Factor XIII is the only coagulation factor deficiency that cannot be detected by classical hemostatic screening tests 4. A newborn with persistent umbilical stump bleeding and normal routine coagulation tests should be screened for Factor XIII deficiency 4, 5.

Management Implications

  • Prophylactic Factor XIII concentrate is required for surgical procedures and trauma 1
  • Genetic counseling is recommended as this is typically an autosomal recessive disorder 1
  • Long-term prophylaxis with cryoprecipitate or plasma-derived Factor XIII concentrate provides excellent prognosis 3
  • Intracranial hemorrhage is a major concern in untreated patients, occurring in up to 30% of cases 3, 5

References

Guideline

Factor XIII Deficiency Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Factor XIII deficiency.

Haemophilia : the official journal of the World Federation of Hemophilia, 2008

Research

Neonatal factor XIII deficiency.

Clinical pediatrics, 1985

Research

Factor XIII deficiency in children--clinical presentation and outcome.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2008

Guideline

Hemophilia B Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the likely cause of a baby's delayed umbilical cord separation and bleeding with normal Prothrombin Time (PT), Partial Thromboplastin Time (PTT), and platelet count and function, but delayed clotting time?
What is the likely diagnosis for a child with umbilical bleeding, normal Prothrombin Time (PT), activated Partial Thromboplastin Time (aPTT), platelet count, and platelet function, but increased clot lysis, and a family history of similar issues?
What is the diagnosis and management for a newborn with umbilical bleeding, normal Prothrombin Time (PT), activated Partial Thromboplastin Time (aPTT), platelet count, and platelet function, but increased clot lysis, with a family history of similar condition?
What is the management for a child with umbilical bleeding, normal prothrombin time (PT), activated partial thromboplastin time (aPTT), platelet count, and platelet function, but increased clot lysis, and a family history of similar bleeding disorders?
What is the likely cause of a newborn's delayed umbilical cord separation and bleeding with normal Prothrombin Time (PT), Partial Thromboplastin Time (PTT), and platelet count and function, but delayed clotting time?
How can I manage insomnia in a patient who develops sleep difficulty after initiating atogepant for migraine prophylaxis?
What is the first‑line treatment for borderline hepatic steatosis?
What are the differences between a nontoxic (simple) goiter and a toxic (toxic multinodular) goiter?
In an adult with ischemic heart disease and documented low serum magnesium but normal renal function, should magnesium be supplemented and what dosing and monitoring are recommended?
In a 45‑kg woman with a single 1.2 cm asymptomatic gallstone that is echogenic, mobile, and casts acoustic shadow on ultrasound, is the stone likely a cholesterol stone?
For a chronic smoker, is coronary artery calcium scoring or abdominal aortic aneurysm ultrasound the preferred screening test?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.